Mirum Pharmaceuticals, Inc. (MIRM)

Nasdaq · Healthcare · Biotechnology
$96.13+0.65%As of 2026-11-22 · USD
Last session low $94.10Last session high $98.39
52-week low $63.2352-week high $130.00
Market cap
$6.28B
Sector
Healthcare

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)63.6In the neutral range (30 to 70)
MACD (12, 26, 9)2.14Above its signal line (1.70); histogram 0.45
Bollinger %B (20, 2)80%Inside the bands (82.47 to 99.62)
SMA 2091.04Price is 5.6% above
SMA 5088.20Price is 9.0% above
SMA 20098.17Price is 2.1% below
ATR (20)4.02% of priceAverage true range per day
52-week position49%In the middle of the 63.23 to 130.00 range

About Mirum Pharmaceuticals, Inc.

Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases.

Insider filings, 90 daysNo purchases and 6 sales (about $7.3M).
Latest fiscal yearEnded 2025-12-31: revenue of $521.31M and an operating margin of -4.2%.

More in Biotechnology